Homepage
Author:
Inovio Pharmaceuticals, Inc.
Posted Date:
April 2, 2026
INOVIO Announces Pricing of $17.5 Million Public Offering
Inovio Pharmaceuticals, Inc.
April 2, 2026
INOVIO Announces Proposed Public Offering
Inovio Pharmaceuticals, Inc.
April 1, 2026
INOVIO to Participate in Upcoming Scientific Conference
Inovio Pharmaceuticals, Inc.
April 1, 2026
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Inovio Pharmaceuticals, Inc.
March 12, 2026
INOVIO to Participate in Upcoming Scientific Conferences
Inovio Pharmaceuticals, Inc.
March 9, 2026
INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
Inovio Pharmaceuticals, Inc.
March 5, 2026
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Inovio Pharmaceuticals, Inc.
March 4, 2026
INOVIO to Participate in Upcoming Scientific and Investor Conferences
Inovio Pharmaceuticals, Inc.
February 12, 2026
